Astrazeneca Covid Vaccine
-
{
- All
- News
- Videos
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Rs 3,000 Crore Boost For Serum Institute Amid Vaccine Shortage: Report
India is set to accept the Serum Institute of India's (SII) request for a 30 billion rupees ($400 million) grant to boost its capacity to make the AstraZeneca COVID-19 vaccine, a government source with knowledge of the matter told Reuters.
-
Italy To Restart AstraZeneca Vaccinations From Friday, Says PM
Italy will resume administering AstraZeneca/Oxford coronavirus vaccines on Friday after the EU's drugs regulator declared them safe, Prime Minister Mario Draghi said.
-
Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears
British Prime Minister Boris Johnson said on Wednesday he will take the vaccine developed by AstraZeneca after a number of European countries halted their rollout of the jab over safety fears.
-
EU Faces Fresh Shortfall Of AstraZeneca Covid Vaccine Supplies
The European Union is facing further shortfalls in its coronavirus inoculation programme after pharmaceutical giant AstraZeneca said production problems and export restrictions would reduce planned deliveries of its vaccine.
-
COVID-19 Vaccine Should Work Against Severe Disease, Says AstraZeneca CEO
AstraZeneca's Chief Executive said on Tuesday that the results of a study showing its COVID-19 vaccine had little effect against mild disease were concerning but stressed that it should work against severe forms.
-
AstraZeneca Hit By Covid Jab Delays And Disagreements In Europe
Only a few weeks ago, Anglo-Swedish pharmaceutical giant AstraZeneca was being applauded for the speed with which it developed its Covid-19 vaccine.
-
AstraZeneca Warns Of Limited Coronavirus Vaccine Supplies To Europe
British pharmaceutical firm AstraZeneca warned Friday that supplies of its coronavirus vaccine to Europe will be "lower than originally anticipated" due to reduced production at a manufacturing site.
-
When And How Will COVID-19 Vaccines Become Available Around The World
Pfizer Inc with partner BioNTech SE and Moderna Inc have released trial data showing their COVID-19 vaccines to be about 95 per cent effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90 per cent effective.
-
Oxford Vaccine Can Be 90% Effective; Serum Institute Is India Partner
AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world another weapon to fight the global pandemic and potentially cheaper to make, easier to distribute and faster to scale-up than rivals. The combined analysis from both dosing regimens resulted in an average efficacy of 70%.
-
AstraZeneca COVID-19 Vaccine Trial Volunteer Dies, Says Brazil
Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.
-
AstraZeneca Covid Vaccine Linked To Another Fatal Blood Clotting Disorder
AstraZeneca's Covid-19 vaccine, made in collaboration with Oxford University has been found to raise the risk of vaccine-induced immune thrombocytopenia and thrombosis (VITT) -- a rare but fatal blood clotting disorder, claimed researchers today.
-
AstraZeneca Admits Covishield Jab Has Rare Side-Effect. Should You Worry?
Thrombosis Thrombocytopenia Syndrome (TTS) -- a blood clot disorder -- is a rare side effect of AstraZeneca's Covid vaccine, and the risks far outweigh the benefits of the jab, doctors said today.
-
European Union Drugs Regulator Approves AstraZeneca Jab As Covid Booster
AstraZeneca's Covid jab has won approval for use as a booster or third jab in the European Union, the British drugs giant confirmed Monday.
-
AstraZeneca Covid Vaccine Protection Wanes After 3 Months: Lancet Study
The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.
-
Cause Of Rare Blood Clots Linked With AstraZeneca, Johnson & Johnson Covid Vaccines Found: Study
Scientists have found a possible trigger behind the extremely rare blood clots linked to AstraZeneca and Johnson & Johnson COVID-19 vaccines, an advance that may help design new and improved preventives against the viral disease.
-
Rs 3,000 Crore Boost For Serum Institute Amid Vaccine Shortage: Report
India is set to accept the Serum Institute of India's (SII) request for a 30 billion rupees ($400 million) grant to boost its capacity to make the AstraZeneca COVID-19 vaccine, a government source with knowledge of the matter told Reuters.
-
Italy To Restart AstraZeneca Vaccinations From Friday, Says PM
Italy will resume administering AstraZeneca/Oxford coronavirus vaccines on Friday after the EU's drugs regulator declared them safe, Prime Minister Mario Draghi said.
-
Boris Johnson Says He Will Have AstraZeneca Vaccine, Dismisses Safety Fears
British Prime Minister Boris Johnson said on Wednesday he will take the vaccine developed by AstraZeneca after a number of European countries halted their rollout of the jab over safety fears.
-
EU Faces Fresh Shortfall Of AstraZeneca Covid Vaccine Supplies
The European Union is facing further shortfalls in its coronavirus inoculation programme after pharmaceutical giant AstraZeneca said production problems and export restrictions would reduce planned deliveries of its vaccine.
-
COVID-19 Vaccine Should Work Against Severe Disease, Says AstraZeneca CEO
AstraZeneca's Chief Executive said on Tuesday that the results of a study showing its COVID-19 vaccine had little effect against mild disease were concerning but stressed that it should work against severe forms.
-
AstraZeneca Hit By Covid Jab Delays And Disagreements In Europe
Only a few weeks ago, Anglo-Swedish pharmaceutical giant AstraZeneca was being applauded for the speed with which it developed its Covid-19 vaccine.
-
AstraZeneca Warns Of Limited Coronavirus Vaccine Supplies To Europe
British pharmaceutical firm AstraZeneca warned Friday that supplies of its coronavirus vaccine to Europe will be "lower than originally anticipated" due to reduced production at a manufacturing site.
-
When And How Will COVID-19 Vaccines Become Available Around The World
Pfizer Inc with partner BioNTech SE and Moderna Inc have released trial data showing their COVID-19 vaccines to be about 95 per cent effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90 per cent effective.
-
Oxford Vaccine Can Be 90% Effective; Serum Institute Is India Partner
AstraZeneca said on Monday its COVID-19 vaccine could be around 90% effective, giving the world another weapon to fight the global pandemic and potentially cheaper to make, easier to distribute and faster to scale-up than rivals. The combined analysis from both dosing regimens resulted in an average efficacy of 70%.
-
AstraZeneca COVID-19 Vaccine Trial Volunteer Dies, Says Brazil
Brazilian health authority Anvisa said on Wednesday that a volunteer in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University has died, stating it had received data from an investigation into the matter.
